For the Inventor, By the Inventor

Enter assignee name

Clondiag Gmbh

USPTO Granted Patents = 17

% Expired Patents = 41.2

CIPO Patents = 2

EPO Patents = 33

Forward Citations = 165

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Torsten Schulz (17 out of 34 patents)

Eugen Ermantraut (16 out of 32 patents)

Thomas Kaiser (9 out of 13 patents)

4. Thomas Ullrich (8 out of 13 patents)

5. Jens Tuchscheerer (6 out of 9 patents)

6. Ralf Bickel (6 out of 7 patents)

7. Thomas Ellinger (3 out of 10 patents)

8. Horst Boessneck (3 out of 3 patents)

9. Katrin Steinmetzer (2 out of 8 patents)

10. Thomas Uhlig (2 out of 4 patents)

11. Alexander Von Schenk Zu Schweinsberg (2 out of 4 patents)

12. Daniel Weicherding (2 out of 3 patents)

13. Vico Baier (2 out of 2 patents)

14. Anke Wöstemeyer (2 out of 2 patents)

15. Klaus-Peter Möbius (1 out of 3 patents)

17 patents: Sort by Forward Citations

1. 9925536 - Assays for measuring nucleic acids (2018-03-27),

2. 9891226 - Assays (2018-02-13),

3. 9791441 - Device and method for the detection of particles (2017-10-17),

4. 9731292 - Assay devices and methods for the detection of analytes (2017-08-15),

5. 9580745 - Method and device for the detection of molecular interactions (2017-02-28),

6. 8916348 - Method and device for the detection of molecular interactions (2014-12-23),

7. 8906303 - Assays (2014-12-09),

8. 8846313 - Assays (2014-09-30),

9. 8828741 - Method and device for the detection of molecular interactions (2014-09-09),

10. 8633013 - Assays (2014-01-21),

11. 8467039 - Device and method for the detection of particles (2013-06-18),

12. 8349616 - Assays (2013-01-08),

13. 8278113 - Assay devices and methods for the detection of analytes (2012-10-02),

14. 8040494 - Device and method for the detection of particles (2011-10-18),

15. D641477 - Device for counting particles in blood (2011-07-12),

Clondiag GmbH is a biotechnology company based in Jena, Germany, specializing in the development of innovative diagnostic solutions for infectious diseases and cancer. The company focuses on molecular diagnostics, leveraging advanced technologies to provide accurate and timely results for healthcare providers. Clondiag's expertise encompasses the design and manufacturing of diagnostic kits and systems, contributing to improved patient outcomes through enhanced disease detection and monitoring.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

17 Patents

#22 in Jena

#2,493 in Germany

#35,887 in the World

Clondiag Gmbh

Forward Citations = 165

17 inventors:

Torsten Schulz (17 out of 34 patents)

Eugen Ermantraut (16 out of 32 patents)

Thomas Kaiser (9 out of 13 patents)

4. Thomas Ullrich (8 out of 13 patents)

5. Jens Tuchscheerer (6 out of 9 patents)

Please report any incorrect information to [email protected]

Loading…